Company: PIII
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001628280-25-026021
Chunk: 60

Company: P3 Health Partners Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 60
---
 common stock warrants issued— — — — — 13,988 — 13,988 Net loss(23,766)— — — — — (20,480)(20,480)STOCKHOLDERS’ EQUITY, March 31, 2025$57,829 3,263 $— 3,919$— $586,923 $(523,673)$63,250 

All periods presented have been retroactively adjusted to reflect the 1-for-50 reverse stock split effected on April 11, 2025. See Note 3 “Significant Accounting Policies” for further information.  

See accompanying notes to condensed consolidated financial statements.

P3 Health Partners Inc. | Q1 2025 Form 10-Q | 7

P3 HEALTH PARTNERS INC. and SUBSIDIARIES 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

Three Months Ended March 31,20252024CASH FLOWS FROM OPERATING ACTIVITIES:Net loss$(44,246)$(49,606)Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization21,052 21,539 Equity-based compensation1,808 1,449 Amortization of original issue discount and debt issuance costs331 (140)Mark-to-market adjustment of stock warrants(3,322)(216)Premium deficiency reserve(6,962)1,000 Changes in operating assets and liabilities:Health plan receivable(8,084)(25,198)Clinic fees, insurance, and other receivable(1,462)2,892 Prepaid expenses and other current assets(558)(3,296)Other long-term assets(14,345)(17)Accounts payable, accrued expenses, and other current liabilities1,593 (5,553)Accrued payroll494 1,542 Health plan settlements payable1,150 (12,944)Claims payable13,575 44,168 Accrued interest5,614 4,387 Operating lease liability(104)(37)Net cash used in operating activities(33,466)(20,030)CASH FLOWS FROM INVESTING ACTIVITIES:Net cash provided by (used in) investing activities— — CASH FLOWS FROM FINANCING